Changes in rat spleen cannabinoid receptors after chronic CP-55,940: An autoradiographic study

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 73-78

  Massi, Paola ^a   Patrini, Gabriela ^a   Rubino, Tiziana ^a   Fuzio, Domenica ^a   Parolaro, Daniela ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cannabinoid receptor; Cannabinoids; Chronic treatment; CP 55,940; Down regulation; Spleen

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CANNABINOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; IMMUNOMODULATION; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SPLEEN CELL;

ANIMALS; AUTORADIOGRAPHY; CANNABINOIDS; CYCLOHEXANOLS; DOWN-REGULATION; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SPLEEN;

ANIMALIA;

EID: 0030819802     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00379-6     Document Type: Article

References (18)

1. Arata S., Klein T. W., Newton C, Friedman H. Tetrahydro- cannabinol treatment suppresses growth restriction of Legionella pneumophila in murine macrophage cultures. Life Sci. 49:1991;473-479.
2. Bouaboula M., Rinaldi M., Carayon P., Carillon C., Delpech B., Shire D., Le Fur G., Casellas P. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214:1993;173-180.
3. Fan F., Tao Q., Abood M., Martin B.R. Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP55,940 on adenylyl cyclase in the cerebellum of CP-55,940-tolerant mice. Brain Res. 706:1996;13-20.
4. Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
5. Goldscheiner I., McGregor D. D. Anatomical distribution of T and B lymphocytes in the rat. Development of lymphocyte-specific antisera. J. Exper. Med. 138:1973;1443-1465.
6. Kaminski N. E., Koh W. S., Yang K. H., Lee M., Kessler F. K. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Biochem. Pharmacol. 10:1994;1899-1908.
7. Klein T. W., Kawakami Y., Newton C., Friedman H. Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J. Toxicol. Environ. Health. 32:1991;465-477.
8. Luo Y. D., Patel M. K., Wiederhold M. D., Ou D. W. Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. Int. J. Immunopharmacol. 14:1992;49-56.
9. Lynn A. B., Herkenham M. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat. Implication for receptor-mediated immune modulation by cannabinoids J. Pharmacol. Exp. Ther. 268:1994;1612-1623.
10. Munro S., Thomas K. L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
11. Munson, A. E.; Fehr, K. O.: Immunological effects of cannabis. In: Fehr, K. O.; Kalant, H. eds. Adverse health and behavioral consequences of cannabis use. Working paper for the ARS-WHO Scientific meeting. Toronto: Addiction Research Foundation, 1983:257-353.
12. Nahas G. G., Suciu-Foca N., Armand J. P., Morishima A. Inhibition of cellular mediated immunity in marijuana smokers. Science. 183:1974;419-420.
13. Nahas G., Latour C. The human toxicity of marijuana. Med. J. Aust. 156:1992;495-497.
14. Oviedo A., Glowa J., Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain. A quantitative autoradiographic study Brain Res. 616:1993;293-302.
15. Rodriguez de Fonseca F., Gorriti M. A., Fernandez-Ruiz J.J., Palomo T., Ramos J. A. Pharmacol. Biochem. Behav. 47:1993;33-40.
16. Romero J., Garcia L., Fernandez-Ruiz J.J., Cebeira M., Ramos J.A. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to Δ-9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 51:1995;731-737.
17. Rubino T., Massi P., Patrini G., Venier I., Giagnoni G., Parolaro D. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain. An in situ hybridization study Neuroreport. 5:1994;2493-2496.
18. Specter S., Lancz G., Westrich G., Friedman H. Δ-9tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int. J. Immunopharmacol. 13:1991;411-417.